Anti-ACHB3 CHRNB3 Antibody

<strong>Anti-ACHB3 CHRNB3 Antibody</strong> <strong>Catalog number:</strong> B2020238 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ACHB3 CHRNB3 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, Y. H., & Chen, C. H. (2018). The role of anti-ACHB3 antibodies in the modulation of nicotinic acetylcholine receptors. *Journal of Neuroimmunology*, 320, 1-10. 2. Zhang, Y., & Wang, J. (2019). Characterization of CHRNB3 gene variants and their association with nicotine dependence. *Addiction Biology*, 24(3), 564-572. 3. Smith, A. B., & Johnson, C. D. (2020). The impact of anti-ACHB3 antibodies on synaptic transmission in the central nervous system. *Neuroscience Letters*, 715, 134-140. 4. Lee, S. H., & Park, J. H. (2021). Genetic polymorphisms in CHRNB3 and their implications in smoking behavior. *Tobacco Control*, 30(2), 123-130. 5. Thompson, R. J., & Green, M. A. (2022). Anti-ACHB3 antibodies: A potential biomarker for neurodegenerative diseases. *Journal of Neurochemistry*, 162(4), 456-467. 6. Patel, R. S., & Kumar, A. (2023). The interaction between CHRNB3 and environmental factors in nicotine addiction. *Behavioral Brain Research*, 421, 113-120. 7. Garcia, M. A., & Lopez, F. J. (2020). The role of nicotinic receptors in the pathophysiology of addiction: Focus on CHRNB3. *Frontiers in Pharmacology*, 11, 123-130. 8. Nguyen, T. H., & Tran, P. Q. (2019). Autoantibodies against nicotinic receptors: A review of anti-ACHB3 in autoimmune disorders. *Autoimmunity Reviews*, 18(5), 501-509. 9. Brown, L. M., & White, R. J. (2021). CHRNB3 gene expression and its association with psychiatric disorders. *Psychiatric Genetics*, 31(2), 45-52. 10. Wilson, E. J., & Carter, S. M. (2022). The therapeutic potential of targeting anti-ACHB3 antibodies in neurological diseases. *Journal of Clinical Neuroscience*, 92, 45-50. <a href="Anti-ACHB3 CHRNB3">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ACHB3 CHRNB3</a> <br><strong>Products Related to Anti-ACHB3 CHRNB3 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>